《Table 2Outcomes of combined hepatocellular-cholangiocarcinoma following hepatectomy and liver trans

  提示：宽带有限、当前游客访问压缩模式

本系列图表出处文件名：随高清版一同展现

《Long-term outcomes of combined hepatocellular-cholangiocarcinoma after hepatectomy or liver transplantation: A systematic review and meta-analysis》

1. 获取 高清版本忘记账户？点击这里登录

1. 下载图表忘记账户？点击这里登录

MOS:median overall survival；LT:liver transplantation；OS:overall survival.a 1 patient underwent liver transplantation；b 4 patients underwent liver transplantation；c 2 patients underwent liver transplantation.

A total of 381 articles were identified by the initial search strategy.Processing according to PRISMA criteria yielded 42publications containing data of 1691 patients who met the final inclusion criteria（Fig.1）.Of them，1390 patients underwent partial hepatectomy and the other 301 patients underwent LT.The characteristics of the included patients are summarized in Table 1[3–23，26–46].All studies were retrospective and classified as level-4 evidence.Most reports originated from Asia（Japan，n=7；Korea，n=14；China，n=11；Saudi Arabia，n=1），followed by the United States（n=6）and Europe（n=3）.